BARTEČEK, Richard, Tomáš KAŠPÁREK and Eva ČEŠKOVÁ. Withdrawal related adverse effects of antipsychotic medication in a patient with first-episode schizophrenia. Central European Journal of Medicine. Warsaw (Poland): Versita, 2011, vol. 6, No 5, p. 662-664. ISSN 1895-1058. Available from: https://dx.doi.org/10.2478/s11536-011-0055-8.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name Withdrawal related adverse effects of antipsychotic medication in a patient with first-episode schizophrenia
Name in Czech Zmínění nežádoucích účinků antipsychotické medikace u pacientů s první epizodou schizofrenie
Authors BARTEČEK, Richard (203 Czech Republic, guarantor, belonging to the institution), Tomáš KAŠPÁREK (203 Czech Republic, belonging to the institution) and Eva ČEŠKOVÁ (203 Czech Republic, belonging to the institution).
Edition Central European Journal of Medicine, Warsaw (Poland), Versita, 2011, 1895-1058.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30000 3. Medical and Health Sciences
Country of publisher Poland
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 0.312
RIV identification code RIV/00216224:14110/11:00053792
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.2478/s11536-011-0055-8
UT WoS 000293708800022
Keywords (in Czech) schizofrenie; antipsychotika; zmírnění nežádoucích účinků
Keywords in English schizophrenia; antipsychotics; withdrawal related adverse effects
Tags International impact
Changed by Changed by: Mgr. Michal Petr, učo 65024. Changed: 2/2/2012 16:12.
Abstract
Withdrawal-emergent adverse effects of antipsychotics are an infrequently identified condition which can appear during antipsychotic dose reduction and medication change. In this paper, we present the case of severe extrapyramidal symptoms after a dose reduction of risperidone is presented. A patient, 23 years of age, was admitted to a health care facility due to an unexpected change in his behavior, with paranoid delusions, incoherent thinking, and significant anxiety. An initial risperidone treatment was soon changed to zuclopenhixol. Subsequently, severe extrapyramidal symptoms appeared, after which the medication was switched back to resperidone. Following this treatment, the patient left the health care facility and stopped the medication of his own volition. Psychotic symptoms and massive extrapyramidal symptoms again occurred. These symptoms subsided only slowly during a subsequent treatment with olanzapine. The development of adverse neurological effects together with a worsening of productive psychotic symptomatology may be explained by withdrawal of antipsychotic medication. These symptoms are often attributed to new medications, which are prematurely discontinued after the appearance of an adverse effect, but which are potentially beneficial to a patient, provided that enough time for a spontaneous subsidence of withdrawal-emergent effects is given. Any change in antipsychotic treatment should be carefully considered and thoroughly planned.
PrintDisplayed: 26/4/2024 05:20